Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H28FN3O3 |
Molecular Weight | 401.4744 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(OCCCN2CCN(CC2)C3=C(F)C=CC=C3)C=CC(NC(C)=O)=C1
InChI
InChIKey=PHOCQBYGUQPMIB-UHFFFAOYSA-N
InChI=1S/C22H28FN3O3/c1-17(27)24-18-8-9-21(22(16-18)28-2)29-15-5-10-25-11-13-26(14-12-25)20-7-4-3-6-19(20)23/h3-4,6-9,16H,5,10-15H2,1-2H3,(H,24,27)
Molecular Formula | C22H28FN3O3 |
Molecular Weight | 401.4744 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Mafoprazine is a phenylpiperazine derivative exerting postsynaptic dopamine D2 receptor blocking activity and alpha-adrenergic activity (alpha 1 receptor blocking activity and alpha 2 receptor stimulating activity). In animal models, mafoprazine demonstrated antipsychotic, aggression-inhibiting and cataleptogenic actions.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P61169 Gene ID: 24318.0 Gene Symbol: Drd2 Target Organism: Rattus norvegicus (Rat) Sources: https://www.ncbi.nlm.nih.gov/pubmed/3411821 |
10.7 nM [Ki] | ||
Target ID: CHEMBL1907610 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3411821 |
12.6 nM [Ki] | ||
Target ID: CHEMBL2093864 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3411821 |
101.0 nM [Ki] |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:31:34 GMT 2023
by
admin
on
Fri Dec 15 15:31:34 GMT 2023
|
Record UNII |
D7UUO54C6N
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29710
Created by
admin on Fri Dec 15 15:31:34 GMT 2023 , Edited by admin on Fri Dec 15 15:31:34 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C057002
Created by
admin on Fri Dec 15 15:31:34 GMT 2023 , Edited by admin on Fri Dec 15 15:31:34 GMT 2023
|
PRIMARY | |||
|
71241
Created by
admin on Fri Dec 15 15:31:34 GMT 2023 , Edited by admin on Fri Dec 15 15:31:34 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105101
Created by
admin on Fri Dec 15 15:31:34 GMT 2023 , Edited by admin on Fri Dec 15 15:31:34 GMT 2023
|
PRIMARY | |||
|
DTXSID50230310
Created by
admin on Fri Dec 15 15:31:34 GMT 2023 , Edited by admin on Fri Dec 15 15:31:34 GMT 2023
|
PRIMARY | |||
|
80428-29-1
Created by
admin on Fri Dec 15 15:31:34 GMT 2023 , Edited by admin on Fri Dec 15 15:31:34 GMT 2023
|
PRIMARY | |||
|
D7UUO54C6N
Created by
admin on Fri Dec 15 15:31:34 GMT 2023 , Edited by admin on Fri Dec 15 15:31:34 GMT 2023
|
PRIMARY | |||
|
100000081718
Created by
admin on Fri Dec 15 15:31:34 GMT 2023 , Edited by admin on Fri Dec 15 15:31:34 GMT 2023
|
PRIMARY | |||
|
SUB08634MIG
Created by
admin on Fri Dec 15 15:31:34 GMT 2023 , Edited by admin on Fri Dec 15 15:31:34 GMT 2023
|
PRIMARY | |||
|
C66047
Created by
admin on Fri Dec 15 15:31:34 GMT 2023 , Edited by admin on Fri Dec 15 15:31:34 GMT 2023
|
PRIMARY | |||
|
6136
Created by
admin on Fri Dec 15 15:31:34 GMT 2023 , Edited by admin on Fri Dec 15 15:31:34 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|